VIP (Vasoactive Intestinal Peptide)
A 28-amino-acid neuropeptide repurposed intranasally for chronic inflammatory response syndrome under the Shoemaker protocol. The clinical evidence is largely from a single practitioner network.
Choose an option
- Pay with Bitcoin
- Discreet shipping within Germany
- Purity-guaranteed batches
- 14-day refund period if unsatisfied
Delivery & guarantee
Orders typically arrive within 3 weeks.
If your delivery arrives late, you'll receive a discount on your next order.
About
VIP is a real endogenous neuropeptide with broad biology (vasodilation, immune modulation, circadian signalling) but the reason it shows up in peptide protocols at all is the Shoemaker CIRS framework. Ritchie Shoemaker and a small network of trained practitioners use intranasal VIP as the last step in a multi-stage protocol for biotoxin illness, after MARCoNS clearance, antigen avoidance, and inflammatory marker stabilisation.
Read the full research guideWhy people choose it
- Reduction of inflammatory and complement markers in CIRS patients who have already completed the upstream steps of the Shoemaker protocol
- Possible improvement in exercise capacity and post-exertional malaise in the same patient group
- Subjective improvements in sleep, mood, and cognitive clarity once inflammation drops
- Useful endpoint marker. Patients who respond often see VCS (visual contrast sensitivity) normalise alongside symptom relief
At a glance
- Experience level
- Advanced
- Administration
- Intranasal · Subcutaneous
Sold for laboratory research only. Not for human consumption. No therapeutic claims are made.
Sign in to view this product
VIP (Vasoactive Intestinal Peptide)
Log in or create a free account to see full details and prices.
Don't have an account? Sign up